Difference between revisions of "Lymph node pathology"

Jump to navigation Jump to search
m (→‎Overview in a table: make sortable)
Line 471: Line 471:
===General===
===General===
*Lymphadenopathy associated with a skin lesion - '''key feature'''.
*Lymphadenopathy associated with a skin lesion - '''key feature'''.
*May be benign or malignant (e.g. T-cell lymphoma).
*May be benign ''or'' malignant (e.g. T-cell lymphoma).


===Microscopic===
===Microscopic===
Line 479: Line 479:
*Plasma cells (medulla).
*Plasma cells (medulla).
*Eosinophils.
*Eosinophils.
Images:
*[http://commons.wikimedia.org/wiki/File:Dermatopathic_lymphadenopathy_-_low_mag.jpg DL - low mag. (WC)].
*[http://commons.wikimedia.org/wiki/File:Dermatopathic_lymphadenopathy_-_intermed_mag.jpg DL - intermed. mag. (WC)].


Histiocytes & special histiocytes:
Histiocytes & special histiocytes:
Line 494: Line 490:
**Need IHC to identify definitively.
**Need IHC to identify definitively.


IHC:
DDx:
*[[Metastatic]] [[malignant melanoma]] - pigmented cells have nuclear atypia, not histiocytes.
 
Images:
*[http://commons.wikimedia.org/wiki/File:Dermatopathic_lymphadenopathy_-_low_mag.jpg DL - low mag. (WC)].
*[http://commons.wikimedia.org/wiki/File:Dermatopathic_lymphadenopathy_-_intermed_mag.jpg DL - intermed. mag. (WC)].
 
===IHC===
*Interdigitating dendritic cells: S100 +ve, CD1a -ve.
*Interdigitating dendritic cells: S100 +ve, CD1a -ve.
*Langerhans cells: S100 +ve, CD1a +ve.
*Langerhans cells: S100 +ve, CD1a +ve.